Download Files:
Vepafestinib
$490 – $4,080
Products Details
Product Description
– Vepafestinib (TAS0953/HM06; compound 6) is a RET inhibitor (extracted from patent WO2019039439)[1]. Vepafestinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Web ID
– HY-132846
Storage Temperature
– -20°C, 3 years (Powder)
Shipping
– Blue Ice
Applications
– Cancer-Kinase/protease
Molecular Formula
– C26H30N6O3
References
– [1]Hayashi, Kohei, et al. FUSION PROTEIN OF DCTN1 PROTEIN WITH RET PROTEIN. WO2019039439.
CAS Number
– 2129515-96-2
Molecular Weight
– 474.55
Compound Purity
– 98.84
SMILES
– O=C(C1=C(C#CCN2CCOCC2)N(C3(C)CC3)C4=NC=NC(N)=C41)NC5=CC=C(COC)C=C5
Clinical Information
– Phase 2
Research Area
– Others
Solubility
– DMSO : 50 mg/mL (ultrasonic)
Target
– RET
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
